Rare diseases
Investigational molecules
Locations
Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa
GermanyStudy on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma
GermanyStudy on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal
GermanyStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
GermanyStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
GermanyLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
GermanyStudy of Pembrolizumab, Olaparib, and Pemetrexed for Patients with Stage IV Non-Small Cell Lung Cancer
GermanyStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
GermanyStudy on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma
GermanyStudy on Tinlarebant for Treating Stargardt Disease in Adolescents
GermanyStudy on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease
GermanyStudy on the Effects of Povorcitinib for Adults with Moderate to Severe Asthma Not Well Controlled
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
